 LEXINGTON, Mass., Nov. 12, 2020 GLOBE NEWSWIRE -- T2 Biosystems, Inc. NASDAQ:TTOO, a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech Diagnostics Forum. 